You are here

29-11-2018 | Pictures and portrait: © Saarland University, HCI Lab

Tech-filled tattoos to interact with the surrounding world

The increasing development of wearable technology sparks the need for new, innovative ways to interact with our shiny gadgets. Deviating from the conventional approach based on touch-sensitive devices, Prof. Jürgen Steimle aims at producing body-worn user interfaces that can be applied directly on the skin. Highly personalised, biocompatible and ultrathin, these devices will seamlessly blend with the human skin to create a technological extension of our body.

12-07-2018 | Image:©Shutterstock

Putting the CRISPR back in bacteria

CRISPR is a widely used molecular biology tool exploiting an immune process discovered in bacteria. Dr David Bikard studies CRISPR in bacterial cells, in conjunction with different DNA repair systems, to create even newer tools. He hopes to gain insight into bacterial genetics, and develop increasingly effective medical treatments.

18-05-2015 | Portrait:© Inria / Photo J.M. Ramès | Image:© Inria - Photo Poppy Project, M. Lapeyre

Poppy, the 3-D printed robot set to inspire innovation in classrooms

It has long been a sci-fi dream to have a humanoid robot in our everyday life. Soon that dream may seem even more vivid, thanks to Dr Pierre-Yves Oudeyer’s ERC-funded project. His team has developed the first complete open-source 3D printed humanoid robot, called “Poppy”. Poppy is a robot that anybody can build – its body is 3D printed and its behaviour programmed by the user. The technology will be of benefit to the fields of science, engineering, education and even the arts.

 

13-03-2013 | Piwi proteins activity (red) protecting the integrity of genetic material, DNA (blue) in the normal development of mouse male germ cells

Unveiling how our genome is protected

Conducting research in small RNAs, Dr. Ramesh Pillai attempts to understand how the genome protects itself from an internal threat, namely ‘transposons’ or ‘jumping genes’ which can cause mutations. Awarded an ERC Starting grant in 2010, Dr. Pillai is based at the European Molecular Biological Laboratory, Grenoble (France).